期刊文献+

荧光染色法检测重组乙型肝炎疫苗中残留DNA含量 被引量:4

Determination of residual DNA content in recombinant hepatitis B vaccine by fluorescent staining
原文传递
导出
摘要 目的采用荧光染色法检测重组乙型肝炎疫苗(酿酒酵母)纯化工艺中间产品、原液及半成品中残留DNA含量。方法采用《中国药典》三部(2010版)附录ⅨB荧光染色法检测重组乙型肝炎疫苗(酿酒酵母)纯化工艺主要中间产品[丁基琼脂糖层析收集液(以下简称BA富集液)]、原液及半成品中残留DNA含量,对该方法的准确度、精密性进行验证,并用建立的方法检测10批BA富集液、原液及半成品中残留DNA含量。结果该方法线性范围1.25~80ng/ml,r^2≥0.999,最低检测限为1.25ng/ml;DNA标准品在BA富集液、疫苗原液及半成品中的平均回收率分别为105.8%、101.4%和108.5%,准确度较好;不同时间点重复测定同一批样品的变异系数(CV)在1.6%-6.56%之间,不同试验间重复测定同一批样品的CV在1.4%-3.6%之间,试验内和试验间精密性较好;10批BA富集液中DNA浓度均较高,经过纯化后,原液中DNA含量明显降低,半成品中除个别批号外,均基本达到低于10ng/剂的要求。结论荧光染色法可用于重组乙型肝炎疫苗(酿酒酵母)纯化工艺中间产品、原液及半成品中残留DNA含量的常规监测,具有简便、快速、自动化程度高等特点,测定前样品无需进行处理。 Objective To determine the residual DNA contents in intermediate products of purification, bulk and final bulk of recombinant hepatitis B (HB) vaccine (S. cerevisiae) by fluorescent staining. Methods The residual DNA contents in intermediate products of purification(harvested liquid of butyl-agarose chromatography, BA enrichment liquid), bulk and final bulk of recombinant HB vaccine(S, cerevisiae ) was determined by fluorescent staining in Appendix ⅨB of Chinese Pharmacopoeia (Volume Ⅲ, 2010 edition), based on which the method was verified for accuracy and precision, and used for determination of 10 batches of BA enrichment liquid, bulk and final bulk. Results The linear range, r2 value and minimum detection limit of the method were 1.25 - 80 ng / ml, not less than 0. 999 and 1.25 ng / ml respectively. The mean recovery rates of DNA standard in BA enrichment liquid, bulk and final bulk were 105. 8%, 101. 4% and 108. 5% respectively, indicating high accuracy of the method. The CVs of repeat determination results at various time points were 1.6% - 6. 56%, while those of the same batch of samples in various tests was 1.4% - 3. 6% indicating high precisions in intra-and inter-assays of the method. The DNA contents were high in 10 batches of BA enriched liquid while decreased significantly in bulk. However, the DNA contents in final bulks, except those in individual batches, were less than 10 ng / dose. Conclusion Fluorescent staining may be used for routine determination of residual DNA contents in intermediate products of purification, bulk and final bulk of recombinant HB vaccine (S. cerevisiae), which is simple, rapid and highly automatic, and the samples need no special treatment before determination.
出处 《中国生物制品学杂志》 CAS CSCD 2013年第11期1652-1655,共4页 Chinese Journal of Biologicals
关键词 荧光染色法 残留DNA 疫苗 乙型肝炎 质量控制 Fluorescence staining Residual DNA Vaccine Hepatitis B Quality control
  • 相关文献

参考文献7

  • 1Hilario E. Overview of hybridization and detection techniques [J]. Methods Mol Biol, 2007, 353( 1): 27-38.
  • 2Wang X, Morgan DM, Wang G, et al. Residual DNA analysis in biologics development: review of measurement and quantitation technologies and future directions [J]. Biotechnol Bioeng, 2012, 109 (2): 307-317.
  • 3Singer VL, Jones LJ, Yue ST, et al. Characterization of Pico- Green reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation [J]. Anal Biochem, 1997, 249 (2): 228-238.
  • 4Georgiou CD, Papapostolou I, Grintzalis K. Protocol for the quantitative assessment of DNA concentration and damage (fra- gmentation and nicks) [J]. Nat Protoc, 2009, 4 (2): 125-131.
  • 5Bolger R, Lenoch F, Allen E, et al. Fluorescent dye assay for detection of DNA in recombinant protein products [J]. Biote- chniques, 1997, 23 (3): 532-537.
  • 6饶春明,赵阳,李永红,王军志.应用荧光法测定重组细胞因子中残余DNA含量[J].药物分析杂志,2005,25(12):1417-1419. 被引量:22
  • 7王兰,高凯,毕华,李永红,饶春明.荧光法和DNA杂交法检测重组技术产品中残余DNA的比较[J].药物分析杂志,2009,29(7):1063-1066. 被引量:30

二级参考文献13

  • 1饶春明,赵阳,李永红,王军志.应用荧光法测定重组细胞因子中残余DNA含量[J].药物分析杂志,2005,25(12):1417-1419. 被引量:22
  • 2EU. Position statement on the use of tumorigenic cells of human origin for the production of biological and bioteehnological medicinal products. The European Agency for the Evaluation of Medieinal Products : Evaluation of medicinal products for human use. CPMP/BWP/1143/ 00 2001.
  • 3FDA. Points to consider in the manufacture and testing of monoclonal antibody products for human use. US Department of Health and Human Services,Food and Drug Administration, Center for Biologics Evaluation and Research 1997.
  • 4WANG Jun-zhi(王军志).Research & Development and Quality Control of Biotechnical Drugs(2nd Ed)(生物技术药物研究开发和质量控制)(第二版).Beijing(北京):Science Press(科学出版社),2007.98.
  • 5Singer VL, Jones LJ, Yue ST, et al. Characterization of PicoGreen reagent and development of a fluorescence - based solution assay for double - stranded DNA quantitation. Anal Biochem, 1997,249 ( 2 ) : 228.
  • 6.ChP(中国药典)2005.Vol Ⅲ(三部)[M].,.203.
  • 7RaoChun—ming(饶春明) Lizuo—gang(李佐刚) DingXi—shen(丁锡申).Detection of residual DNAin rhIFN—α1b by using biotin—lebaled probe(采用生物素探针检测rhIFN—α1b中外源DNA含量)[J].中国生物制品学杂志,1990,3:70-70.
  • 8Chadwick RB, Conrad MP, McGinnis MD ,et al. Heterozygote and mutation detection by direct automated fluorescent DNA sequencing using a mutant Taq DNA polymerase. Biotechniques. 1996 Apr;20 (4) :676.
  • 9Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980 Mar 1 ;102(2) :344.
  • 10Singer VL, Jones LJ, Yue ST et al. Characterization of Pico Green reagent and development of a fluorescence - based solution assay for double - stranded DNA quantitation. Anal Biochem. 1997 Jul 1 ; 249(2) :228.

共引文献39

同被引文献27

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部